John’s practice focuses on corporate and securities law matters, with emphasis on the biotechnology, medical device and technology industries.
John represents issuers preparing for and completing initial public offerings, de-SPAC and reverse merger transactions, follow-on offerings, ATM offerings and PIPEs. John also represents underwriters in capital markets transactions. In addition, John serves as outside corporate and securities counsel to public companies and advises on a broad range of corporate governance and securities compliance matters, including SEC requirements, Nasdaq and NYSE listing rules and proxy advisory firm policies.
John also advises entrepreneurs of early stage companies on formation, capital raising transactions and corporate governance matters, including through his involvement with the Massachusetts Medical Device Development Center (M2D2).
Prior to becoming an attorney, John worked as a legal assistant in the Securities Litigation Practice at Mintz Levin. He also interned at the Boston College Legal Assistance Bureau, the Massachusetts Clients’ Security Board of the Supreme Judicial Court, the Massachusetts Attorney General’s Office, and the U.S. Senate Committee on the Judiciary.
viewpoints
SEC Adopts Final Cybersecurity Rules for Public Companies
August 1, 2023 | Blog | By Cynthia Larose, John Condon, Michael Katz, Stefan Jović
The SEC adopted its final rules and amendments concerning cybersecurity risk management, strategy, governance, and incident disclosure (the “Final Rule”) on July 26, 2023. In this article we highlight some of the principal changes to the cybersecurity rules first proposed by the SEC more than 16 months prior.
Read more
SEC Adopts Final Cybersecurity Rules for Public Companies
August 1, 2023 | Blog | By Cynthia Larose, John Condon, Michael Katz, Stefan Jović
The SEC adopted its final rules and amendments concerning cybersecurity risk management, strategy, governance, and incident disclosure (the “Final Rule”) on July 26, 2023. In this article we highlight some of the principal changes to the cybersecurity rules first proposed by the SEC more than 16 months prior.
Read more
A Quantitative Analysis of Comment Letters Issued by the SEC Concerning Climate Change Disclosures
June 8, 2023 | Advisory | By Jacob Hupart, Doug Baumstein, Thomas R. Burton, III, John Condon, Will G. McKitterick, Jaidyn M. Jackson, Tucker Kelsch
From July 2021 through March 2023, the SEC sent reporting entities more than 100 letters seeking information on climate change topics and nearly 170 letters concerning greenwashing. In an in-depth analysis, Mintz attorneys identify and analyze the frequency of various categories of questions as well as the industries and characteristics of the businesses targeted.
Read more
Preparation for 2022 Fiscal Year-End SEC Filings and 2023 Annual Shareholder Meetings
December 7, 2022 | Advisory | By John Condon, Anne Bruno, Melanie Ruthrauff Levy, Jacob Hupart, Cynthia Larose, Breton Leone-Quick, Page R. Hubben
SEC Proposes New Cybersecurity Rules for Public Companies
March 21, 2022 | Advisory | By Roman M. Gorokhov, Cynthia Larose, Megan Gates, John Condon
Preparation for 2021 Fiscal Year-End SEC Filings and 2022 Annual Shareholder Meetings
January 18, 2022 | Advisory | By Megan Gates, John Condon, Anne Bruno, Melanie Ruthrauff Levy, Daniel T. Kajunski, Cynthia Larose, Breton Leone-Quick, Page R. Hubben
Read about key regulatory and other developments, including board diversity and other ESG matters, which public companies need to consider as they prepare for their fiscal year-end SEC filings and 2022 annual shareholder meetings.
Read more
Preparation for 2020 Fiscal Year-End SEC Filings and 2021 Annual Shareholder Meetings
January 21, 2021 | Advisory | By Megan Gates, John Condon, Daniel T. Kajunski, Anne Bruno
Read about regulatory and other developments public companies need to consider as they prepare for fiscal year-end Securities and Exchange Commission filings and 2021 annual shareholder meetings.
Read more
Preparation for 2019 Fiscal Year-End SEC Filings and 2020 Annual Shareholder Meetings
January 23, 2020 | Advisory | By Megan Gates, John Condon, Anne Bruno
Read about regulatory developments affecting public companies as they prepare for fiscal year-end Securities and Exchange Commission filings and annual shareholder meetings.
Read more
SEC Requires Public Companies to Hyperlink Exhibits Beginning September 1, 2017
March 28, 2017 | Blog | By John Condon
Public companies will soon be required to include an active hyperlink to each exhibit to all registration statements filed under the Securities Act of 1933, as amended, and all periodic and current reports filed under the Securities Exchange Act of 1934, as amended, filed on or after September 1, 2017.
Read more
News & Press
How The U.S. Supreme Court’s Upcoming Decision In Slack v. Pirani May Tilt The Legal Playing Field Between Investors And Issuers
April 28, 2023
Members Douglas P. Baumstein and John Condon, and Associates Patrick McDonough and Aaron Megar co-authored an article published in the May 2023 Issue of The Banking Law Journal. The article provides an in depth review of the case Slack Technologies, LLC v. Pirani.
Deal Diary: Orrick, Paul Weiss, Mintz On Ipsen Deal For Albireo
January 9, 2023
Mintz's role acting for biotechnology company Albireo Pharma in its sale to Ipsen was covered in The Deal. The article featured Mintz Members Megan Gates, and John Condon and Associate Garrett Galvin, who led for the firm.
Mintz Advises Quantum-SI in $1.46 Billion SPAC Merger
February 19, 2021
Firm plays a key role in the largest health care acquisition to date in 2020.
Mintz Promotes Eleven Attorneys to Member
May 10, 2019
Mintz represented G1 Therapeutics, Inc. in its initial public offering of 7,781,564 shares of common stock. G1 Therapeutics is a clinical-stage biopharmaceutical company.
Mint has been named an official gold sponsor of the MIT 100K Entrepreneurship Competition. The event is a launch pad for students and researchers in the MIT community to act on their talent, ideas, and energy to produce tomorrow’s leading ventures.
Events & Speaking
Speaker
Apr
1
2023
Aspiring Public Company Director Program
National Association of Corporate Directors – New England Chapter
Speaker
Speaker
Sep
28
2022
Introduction to Public Company/Securities Law – Part 2: Public Company Reporting and the Securities Exchange Act of 1934
Boston Bar Association
Online
Speaker
May
13
2021
Disclosure, Financing, and Executive Compensation Basics for New and Aspiring Public Company Executives
Boston Bar Association
Webinar
Speaker
Speaker
Panelist
Panelist
Read less
Involvement
- Co-Chair, Business Transactions Section of the Boston Bar Association, Past Co-Chair of the Securities Law Committee of the Boston Bar Association
- Board of Directors, United Methodist Foundation of New England
- Advisory Board, The Massachusetts Medical Device Development Center (M2D2)
- Contributor, Securities Matters blog
- Mentor, including for the M2D2 $200K Challenge and MIT $100K Pitch Contest
- Member of the Endowment Committee; Past Chair of Church Council, Associate Lay Leader and Member of Pastor Transition Team, Sudbury United Methodist Church
Recent Insights
SEC Adopts Final Cybersecurity Rules for Public Companies
August 1, 2023 |Blog
